medigraphic.com
ISSN 0035-0052 (Impreso)

2010, Número 1

<< Anterior

Rev Mex Pediatr 2010; 77 (1)


Displasia broncopulmonar

Gasque GJJ

Idioma: Español
Referencias bibliográficas: 80
Paginas: 27-37
Archivo PDF: 103.78 Kb.


RESUMEN

La displasia broncopulmonar (DBP) es la enfermedad pulmonar crónica más frecuente en los recién nacidos, afecta predominantemente a neonatos prematuros con muy bajo peso al nacer. En las pasadas dos décadas ha aumentado la incidencia de esta enfermedad, paralelamente a la mejoría en los índices de supervivencia en estos neonatos. Con la finalidad de unificar el criterio diagnóstico de la DBP, en el año 2000 el Instituto Nacional de Salud de Estados Unidos sugirió una nueva definición. La nutrición juega un importante rol en la maduración normal del pulmón y en la reparación del daño. No hay evidencia que afirme que la terapia con broncodilatadores y diuréticos tenga algún beneficio a largo plazo. El empleo de esteroides sistémicos debe restringirse, ya que condicionan secuelas neurológicas. A pesar de los avances en la prevención y tratamiento, la DBP continúa siendo la principal causa de morbilidad y mortalidad a largo plazo en los recién nacidos pretérmino y con peso menor de 1,500 g al nacer.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. following respiratory therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967; 276(7): 357-68.

  2. Bancalari E, Gerhard T. Displasia broncopulmonar. Clin Pediatr North Am 1986; 33: 1-23.

  3. Shennan AT, Dunn MS, Ohlsson A, Lennox K. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82(4): 527-32.

  4. Van Marter LJ, Pagano M, Allred EN, Levinton A, Kuban KCK. Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices. J Pediatr 1992; 120: 938-46.

  5. Davies JM, Rosenfeld WN. Chronic lung disease. In: Avery’s Neonatology. Pathophysiology and management of the newborn 6th ed. Lippincott Williams & Wilkins 2005: 578-99.

  6. Tapia JL, Sola A. Enfermedad pulmonar crónica. En: Sola A, Urman J. Cuidados intensivos neonatales. 4a ed. Científica Interamericana 2002: 1170-88.

  7. Parad RB. Bronchopulmonary dysplasia. In: Cloherty JP, Eichenwald EC, Stark AR. Manual of neonatal care. 6th ed. 2008: 373-82.

  8. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. NICHD/NHLB/ORD Workshop Summary. Am J Respir Crit Care Med 2001; 163: 1723-29.

  9. American Thoracic Society Documents Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 2003; 168: 356-96.

  10. Hernández RL, Téllez CJF, Salinas RV, Zapata PJA. Factores de riesgo para el desarrollo de displasia broncopulmonar neonatal en el Instituto Nacional de Perinatología. Bol Med Hosp Infant Mex 2002; 59: 461-69.

  11. Yunes ZJLM, Ávila RR, Velázquez QN. Displasia broncopulmonar: Una enfermedad contemporánea. Bol Med Hosp Infant Mex 2002; 59: 504-13.

  12. Pérez PG, Barrio GMI, Luna PC, Rueda ES, Pérez TS, Machuca C. Displasia broncopulmonar-enfermedad pulmonar crónica. AEP 2003; 3: 235-44.

  13. Jobe AH. Antenatal factors and development of bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 9-17.

  14. Van Marter LJ, Levinton A, Allred EN, Pagano M, Kuban KCK. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J Pediatr 1990; 116: 942-49.

  15. Sosenko IRS, Rodriguez-Pierce M, Bancalari E. Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants. J Pediatr 1993; 123: 975-82.

  16. Eronen M, Pesonen E, Kurki T, Teramo K, Yikorkala O, Hallman M. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr 1994; 124: 782-88.

  17. Lal MK, Manktelow BN, Draper ES, Field DJ. Chronic lung disease and intrauterine growth retardation. A population based study. Pediatrics 2003; 111: 483-87.

  18. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995; 126: 605-10.

  19. Bancalari E, Claure N, Sosenko IRS. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 2003; 8: 63-71.

  20. Adams JM, Stark AR. Pathogenesis and clinical features of bronchopulmonary dysplasia. Up to Date 2004; 12(3): 1-9.

  21. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 73-81.

  22. Christensen RD, Hunter DD, Goodel H, Rothstein G. Evaluation of the mechanism causing anemia in infants with bronchopulmonary dysplasia. J Pediatr 1992; 120: 593-98.

  23. Puangco MA, Schlander RJ. Clinical experience in enteral nutrition support for premature infants with bronchopulmonar dysplasia. J Perinatol 2000; 2: 87-91.

  24. Biniwale MA, Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 200-08.

  25. Ambalavanan N, Carlo WA. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 192-99.

  26. Bancalari E, Wilson D, Iben SC. Management of infants with bronchopulmonary dysplasia in North America. Early Human Development 2005; 81: 171-79.

  27. Adams JM, Stark A. Management of bronchopulmonary dysplasia. Up to Date 2008: 16(1).

  28. Lenney W. Neumopatía crónica/displasia broncopulmonar en el lactante. ¿Cuál es el tratamiento? An Pediatr Barc 2004; 60(2): 113-16.

  29. Thomas W, Speer CP. Management of infants with bronchopulmonary dysplasia in Germany. Early Human Development 2005; 81: 155-63.

  30. Shaw NJ, Kotecha S. Management of infants with chronic lung disease of prematurity in the United Kingdom. Early Human Development 2005; 81: 165-70.

  31. Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman SH et al. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 2006; 117(3): 552-56.

  32. Thomas W, Speer CP. Prevention and treatment of bronchopulmonary dysplasia: Current status and future prospects. J Perinatol 2007; 27 Suppl: 26-32.

  33. Cerny L, Torday JS, Rehan VK. Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook. Lung 2008; 186: 75-89.

  34. American Academy of Pediatrics, Canadian Paediatric Society (fetus and newborn committee). Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109: 330-38.

  35. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, Mullen MP. Pulmonary artery hypertension in formerly infants with bronchopulmonary dysplasia: Clinical features and outcome in the surfactant era. Pediatrics 2007; 120: 1260-69.

  36. Mourani PM, Sontag MK, Younoszai A, Ivy DD, Steven H. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 2008; 121: 317-25.

  37. Banks BA, Seri I, Ischiropoulos H, Merrill J, Rychik J, Ballard RA. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics 1999; 103: 610-18.

  38. Hon KL, Cheung KL, Siu KL, Leung TF, Yam MC, Fok TF, Ng PC. Oral sildenafil for treatment of severe pulmonary hypertension in an infant. Biol Neonate 2005; 88(2): 109-12.

  39. Huysman WA, De Ridder M, De Bruin NC, Van Helmond G, Terpstra N, Van Goudoever JB et al. Growth and body composition in preterm infants with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal 2003; 88: F46-51.

  40. Short EJ, Klein NK, Lewis BA, Fulton S, Eisengart S, Kercsmar C et al. Cognitive and academic consequences of bronchopulmonary dysplasia in very low birth weight: 8-year-old outcomes. Pediatrics 2003; 112: 359-66.

  41. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967; 276(7): 357-68.

  42. Bancalari E, Gerhard T. Displasia broncopulmonar. Clin Pediatr North Am 1986; 33: 1-23.

  43. Shennan AT, Dunn MS, Ohlsson A, Lennox K. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82(4): 527-32.

  44. Van Marter LJ, Pagano M, Allred EN, Levinton A, Kuban KCK. Rate of bronchopulmonary dysplasia as a function of neonatal intensive care practices. J Pediatr 1992; 120: 938-46.

  45. Davies JM, Rosenfeld WN. Chronic lung disease. In: Avery’s Neonatology. Pathophysiology and management of the newborn 6th ed. Lippincott Williams & Wilkins 2005: 578-99.

  46. Tapia JL, Sola A. Enfermedad pulmonar crónica. En: Sola A, Urman J. Cuidados intensivos neonatales. 4a ed. Científica Interamericana 2002: 1170-88.

  47. Parad RB. Bronchopulmonary dysplasia. In: Cloherty JP, Eichenwald EC, Stark AR. Manual of neonatal care. 6th ed. 2008: 373-82.

  48. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. NICHD/NHLB/ORD Workshop Summary. Am J Respir Crit Care Med 2001; 163: 1723-29.

  49. American Thoracic Society Documents Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 2003; 168: 356-96.

  50. Hernández RL, Téllez CJF, Salinas RV, Zapata PJA. Factores de riesgo para el desarrollo de displasia broncopulmonar neonatal en el Instituto Nacional de Perinatología. Bol Med Hosp Infant Mex 2002; 59: 461-69.

  51. Yunes ZJLM, Ávila RR, Velázquez QN. Displasia broncopulmonar: Una enfermedad contemporánea. Bol Med Hosp Infant Mex 2002; 59: 504-13.

  52. Pérez PG, Barrio GMI, Luna PC, Rueda ES, Pérez TS, Machuca C. Displasia broncopulmonar-enfermedad pulmonar crónica. AEP 2003; 3: 235-44.

  53. Jobe AH. Antenatal factors and development of bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 9-17.

  54. Van Marter LJ, Levinton A, Allred EN, Pagano M, Kuban KCK. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J Pediatr 1990; 116: 942-49.

  55. Sosenko IRS, Rodriguez-Pierce M, Bancalari E. Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants. J Pediatr 1993; 123: 975-82.

  56. Eronen M, Pesonen E, Kurki T, Teramo K, Yikorkala O, Hallman M. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr 1994; 124: 782-88.

  57. Lal MK, Manktelow BN, Draper ES, Field DJ. Chronic lung disease and intrauterine growth retardation. A population based study. Pediatrics 2003; 111: 483-87.

  58. Rojas MA, Gonzalez A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995; 126: 605-10.

  59. Bancalari E, Claure N, Sosenko IRS. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 2003; 8: 63-71.

  60. Adams JM, Stark AR. Pathogenesis and clinical features of bronchopulmonary dysplasia. Up to Date 2004; 12(3): 1-9.

  61. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 73-81.

  62. Christensen RD, Hunter DD, Goodel H, Rothstein G. Evaluation of the mechanism causing anemia in infants with bronchopulmonary dysplasia. J Pediatr 1992; 120: 593-98.

  63. Puangco MA, Schlander RJ. Clinical experience in enteral nutrition support for premature infants with bronchopulmonar dysplasia. J Perinatol 2000; 2: 87-91.

  64. Biniwale MA, Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 200-08.

  65. Ambalavanan N, Carlo WA. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 192-99.

  66. Bancalari E, Wilson D, Iben SC. Management of infants with bronchopulmonary dysplasia in North America. Early Human Development 2005; 81: 171-79.

  67. Adams JM, Stark A. Management of bronchopulmonary dysplasia. Up to Date 2008: 16(1).

  68. Lenney W. Neumopatía crónica/displasia broncopulmonar en el lactante. ¿Cuál es el tratamiento? An Pediatr Barc 2004; 60(2): 113-16.

  69. Thomas W, Speer CP. Management of infants with bronchopulmonary dysplasia in Germany. Early Human Development 2005; 81: 155-63.

  70. Shaw NJ, Kotecha S. Management of infants with chronic lung disease of prematurity in the United Kingdom. Early Human Development 2005; 81: 165-70.

  71. Walsh MC, Szefler S, Davis J, Allen M, Van Marter L, Abman SH et al. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 2006; 117(3): 552-56.

  72. Thomas W, Speer CP. Prevention and treatment of bronchopulmonary dysplasia: Current status and future prospects. J Perinatol 2007; 27 Suppl: 26-32.

  73. Cerny L, Torday JS, Rehan VK. Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook. Lung 2008; 186: 75-89.

  74. American Academy of Pediatrics, Canadian Paediatric Society (fetus and newborn committee). Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002; 109: 330-38.

  75. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, Mullen MP. Pulmonary artery hypertension in formerly infants with bronchopulmonary dysplasia: Clinical features and outcome in the surfactant era. Pediatrics 2007; 120: 1260-69.

  76. Mourani PM, Sontag MK, Younoszai A, Ivy DD, Steven H. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 2008; 121: 317-25.

  77. Banks BA, Seri I, Ischiropoulos H, Merrill J, Rychik J, Ballard RA. Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics 1999; 103: 610-18.

  78. Hon KL, Cheung KL, Siu KL, Leung TF, Yam MC, Fok TF, Ng PC. Oral sildenafil for treatment of severe pulmonary hypertension in an infant. Biol Neonate 2005; 88(2): 109-12.

  79. Huysman WA, De Ridder M, De Bruin NC, Van Helmond G, Terpstra N, Van Goudoever JB et al. Growth and body composition in preterm infants with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal 2003; 88: F46-51.

  80. Short EJ, Klein NK, Lewis BA, Fulton S, Eisengart S, Kercsmar C et al. Cognitive and academic consequences of bronchopulmonary dysplasia in very low birth weight: 8-year-old outcomes. Pediatrics 2003; 112: 359-66.




2020     |     www.medigraphic.com